)
India: New COVID drug gets regulator's nod
Indian pharmaceutical firm Zydus Cadila announced that it has received emergency use approval from the Drug Controller General of India (DGCI) for its antiviral drug Virafin.
Indian pharmaceutical firm Zydus Cadila announced that it has received emergency use approval from the Drug Controller General of India (DGCI) for its antiviral drug Virafin.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)